Pukang

BiotechnologySeries BChengdu, Chinapu-kang.com

Latest round

Series B

Last raised

Jun 2024

Total raised

Undisclosed

Investors

7

About Pukang

Founded in 2008 and based in Chengdu, China, Pukang is a biotech company that focuses on the research and development of long-acting peptide drug side chains and single-molecule PEG derivatives. By 2024, the company has a 3,000-square-meter small-scale test laboratory, a 2,000-square-meter pilot laboratory and a 30,000-square-meter production base that meets GMP requirements. The company's main products include nucleic acid drug raw materials, PEGS blocks and small molecule compounds. PEGS blocks include FMOC-PEG building blocks, Cbz-PEG building blocks and DPEG biotinylated building blocks. The company’s revenue is generated by providing small molecule PEG derivative molecular blocks.

Who invested in Pukang

7 investors across 3 rounds

See all investors in Pukang

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Jun 6, 2024

    Amount

    Undisclosed

    Investors

    Locked

  2. Series B

    Oct 13, 2023

    Amount

    Undisclosed

    Investors

    Locked

  3. Series A

    Jul 23, 2021

    Amount

    Undisclosed

    Investors

    Locked

Questions about Pukang

Who invested in Pukang?

Pukang has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Pukang raised?

Pukang has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Pukang last raise money?

Pukang's most recent round on record is a Series B, in Jun 2024.

What does Pukang do?

Founded in 2008 and based in Chengdu, China, Pukang is a biotech company that focuses on the research and development of long-acting peptide drug side chains and single-molecule PEG derivatives.

Where is Pukang headquartered?

Pukang is headquartered in Chengdu, China.

Which VCs invest in companies like Pukang?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Pukang's stage. Their profiles are linked below.

Raising like Pukang? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.